Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: J Neurooncol. 2022 Apr 5;157(3):465–473. doi: 10.1007/s11060-022-03990-0

Table 1.

Demographic and Clinical Characteristics of the Sample (N = 164)

n (%)

Gender
Male 104 63.4
Female 60 36.6
Race
White 129 78.7
Black 12 7.3
Asian 9 5.5
Pacific Islander 1 0.6
Multi-racial 13 7.9
Extent of Surgical Resection a
STR 13 7.9
NTR 19 11.6
GTR 132 80.5
PFS b
No 118 72.0
Yes 44 26.8
Unknownc 2 1.2

Mean ± SD Range

Age at Diagnosis 10.38 ± 5.09 3.17 – 31.33
Number of Resections d 1.18 ± 0.46 1 – 4
Days from resection until resolution of mutism 36.09 ± 40.51 3 – 244
a

STR subtotal resection, incomplete tumor resection with gross residual disease present on neuroimaging, NTR near total resection, incomplete tumor resection with minimal residual disease present on post-operative neuroimaging, GTR gross total resection, resection of tumor without apparent gross residual disease observed by the operating neurosurgeon and confirmed on operative neuroimaging

b

PFS osterior fossa syndrome

c

Unknown classified as neither “yes” or “no” PFS diagnosis by post-surgical attending physician; participants were excluded from primary analyses

d

The distribution for number of resections included: 1 resection (n=138), 2 resections (n=23), 3 resections (n=2), 4 resections (n=1)